Business / Finance

RSS

Auxilium Pharmaceuticals’ net revenues increase $125.9M to 56%

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced financial results for the fourth quarter and full year ending December 31, 2013. The Company also highlighted select commercial, regulatory and clinical development progress and future goals and provided financial guidance for 2014.

28 Feb 2014

Endo Health Solutions Reports net loss of $776M in fourth quarter 2013

Endo Health Solutions today reported fourth quarter 2013 revenues of $585 million, compared to $750 million for the same quarter of 2012.

28 Feb 2014

Ortho Development receives FDA clearance for patented Knee Articulating Spacer Molds

Ortho Development Corporation has received FDA clearance for its patented KASM Knee Articulating Spacer Molds. KASM is a cement spacer mold intended for use in treating patients who develop an infection after undergoing total knee replacement surgery.

28 Feb 2014

Vétoquinol acquires Bioniche's Animal Health business

Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced their signing of a share purchase agreement under which Vétoquinol has agreed to purchase Bioniche's Animal Health business for the cash purchase price of CAD$61 million.

28 Feb 2014

University of Sheffield showcases its world-class scientists and facilities to businesses

National and international businesses will find out how the University of Sheffield’s world-class scientists and state-of-the-art facilities can take their research and development to the next level during a free networking event on Thursday.

27 Feb 2014

NxStage Medical revenue increases 7% to $69.4 million in fourth quarter 2013

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record financial results for the three and twelve months ended December 31, 2013, that include revenue slightly above its recent guidance.

27 Feb 2014

Ophthotech reports net loss of $20.4 million for fourth quarter 2013

Ophthotech Corporation today announced financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on the Company's business and product development programs.

27 Feb 2014

Covidien closes acquisition of Given Imaging

Covidien plc today announced that it has closed its acquisition of Given Imaging Ltd., providing the company additional scale and scope to serve a significant medical specialty, the multibillion dollar global gastrointestinal (GI) market.

27 Feb 2014

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today reported financial results for the three months and year ended December 31, 2013, and provided an update of recent corporate developments.

27 Feb 2014

Valeant Pharmaceuticals total revenues up 109% in fourth quarter 2013

Valeant Pharmaceuticals International, Inc. announces fourth quarter financial results for 2013.

27 Feb 2014

Prothelia and University of Nevada, Reno enter into agreements with Alexion for development of Laminin-111

Prothelia Incorporated (Prothelia) and University of Nevada, Reno announce that they have entered into strategic agreements with Alexion for the development of Laminin-111, a patented experimental protein replacement therapy for merosin-deficient congenital muscular dystrophy (MDC1A), a life-threatening, ultra-rare disease caused by a genetic deficiency of the Laminin-211 protein.

26 Feb 2014

ViroXis signs agreement with global pharmaceutical for marketing of OTC sandalwood oil-containing product

ViroXis Corporation is pleased to report the execution of an exclusive license agreement with a global pharmaceutical company for the marketing of an over-the-counter (OTC) sandalwood oil-containing product.

26 Feb 2014

Santalis Pharmaceuticals partners with TFS for marketing of OTC dermatology products

Santalis Pharmaceuticals Inc., a joint venture with TFS Corporation Ltd., of Australia (ASX: TFC) is pleased to report the execution of an exclusive license agreement with a global pharmaceutical company for the marketing of a number of over-the-counter (OTC) dermatology products containing TFS' sustainably cultivated, pharmaceutical-grade East Indian Sandalwood Oil (EISO).

26 Feb 2014

K-PAX Pharmaceuticals works with Stanford University to identify effective treatment for chronic fatigue

K-PAX Pharmaceuticals is working with Stanford University and several other leading research institutions to perform a Phase II double-blind, placebo-controlled trial to evaluate the safety and efficacy of a currently available FDA-approved medication concurrently administered with a novel mitochondrial support product in order to identify a safe and effective treatment for the chronic fatigue and decreased alertness (i.e. brain fog) that commonly afflicts people with CFS.

26 Feb 2014

Quest Diagnostics hosts series of "Tech Talks" and programs during HIMSS 2014

Quest Diagnostics, the world's leading provider of diagnostic information services, will exhibit at booth 3064 and host a series of "Tech Talks" and other programs during the HIMSS 2014 Annual Conference & Exhibition, the industry's largest health IT educational program and exhibition February 23 – 27 in Orlando, Florida.

From Quest Diagnostics 26 Feb 2014

Agilent and CambTEK partner to co-market RES automated sample preparation technology

Agilent Technologies Inc. (NYSE:A) and CambTEK, Ltd. today announced an agreement to co-market CambTEK's Rapid Extraction System (RES) automated sample preparation technology with an assortment of Agilent's liquid phase separation, life science and chemical analysis instruments and software.

26 Feb 2014

Seno Medical Instruments sells $34.6 million of $39 million Series C equity funding round

Seno Medical Instruments, Inc., the company pioneering opto-acoustic imaging as a tool to improve the process of diagnosing breast cancer, today announced that it has sold $34.6 million of a $39 million Series C equity funding round from existing investors with the lead investment from MedCare Investment Funds.

25 Feb 2014

Healthy Directions launches Krill Omega Defense

Healthy Directions, LLC, today announced the launch of Krill Omega Defense™, a unique krill supplement formulated by Julian Whitaker, MD, that supports and maintains the health of the body's key biological functions and systems—from the heart, brain, and nerves to the eyes and bones.

25 Feb 2014

Toshiba introduces strategy to establish healthcare business

Toshiba Corporation has introduced the strategy that it will promote to establish its healthcare business as a third main pillar of operations, along with its energy and storage businesses.

25 Feb 2014

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved TIVORBEX™ (indomethacin) capsules, a nonsteroidal anti-inflammatory drug (NSAID), at 20 mg and 40 mg doses for the treatment of mild to moderate acute pain in adults.

25 Feb 2014

Business / Finance

Auxilium Pharmaceuticals’ net revenues increase $125.9M to 56%

Endo Health Solutions Reports net loss of $776M in fourth quarter 2013

Ortho Development receives FDA clearance for patented Knee Articulating Spacer Molds

Vétoquinol acquires Bioniche's Animal Health business

University of Sheffield showcases its world-class scientists and facilities to businesses

NxStage Medical revenue increases 7% to $69.4 million in fourth quarter 2013

Ophthotech reports net loss of $20.4 million for fourth quarter 2013

Covidien closes acquisition of Given Imaging

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

Valeant Pharmaceuticals total revenues up 109% in fourth quarter 2013

Prothelia and University of Nevada, Reno enter into agreements with Alexion for development of Laminin-111

ViroXis signs agreement with global pharmaceutical for marketing of OTC sandalwood oil-containing product

Santalis Pharmaceuticals partners with TFS for marketing of OTC dermatology products

K-PAX Pharmaceuticals works with Stanford University to identify effective treatment for chronic fatigue

Quest Diagnostics hosts series of "Tech Talks" and programs during HIMSS 2014

Agilent and CambTEK partner to co-market RES automated sample preparation technology

Seno Medical Instruments sells $34.6 million of $39 million Series C equity funding round

Healthy Directions launches Krill Omega Defense

Toshiba introduces strategy to establish healthcare business

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News